| 000 | 01111 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513233225.0 | ||
| 264 | 0 | _c20010322 | |
| 008 | 200103s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(05)71475-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWitt, M D | |
| 245 | 0 | 0 |
_aVitamin K for warfarin-associated coagulopathy. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cMar 2001 |
||
| 300 |
_a718 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 |
_aBlood Coagulation Disorders _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInternational Normalized Ratio |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThromboembolism _xetiology |
| 650 | 0 | 4 |
_aVitamin K _xtherapeutic use |
| 650 | 0 | 4 |
_aWarfarin _xadverse effects |
| 700 | 1 | _aPatel, R | |
| 700 | 1 | _aTillman, D J | |
| 700 | 1 | _aWilkinson, D S | |
| 773 | 0 |
_tLancet (London, England) _gvol. 357 _gno. 9257 _gp. 718 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(05)71475-6 _zAvailable from publisher's website |
| 999 |
_c11184474 _d11184474 |
||